Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose in pediatric NAFLD
NCT00677521Phase 2Terminated
- Sponsor
- SickKids
- Start
- Jan 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of acarbose in non-alcoholic fatty liver disease (NAFLD), sponsored by SickKids. Primary endpoint: Hepatic steatosis measured by proton magnetic resonance spectroscopy at 12 weeks. Started Jan 2007; status: terminated.
02
Drugs
acarbose
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT00677521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00677521.